Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 6592 record(s)

Req # A-2024-000458

Seeking drug product testing and/or lot release results conducted by Health Canada or any other external party concerning Comirnaty COVID-19 vaccine and SpikeVax COVID-19 vaccines.

Organization: Health Canada

118 page(s)
October 2024

Req # A-2024-000471

The Imperial Tobacco Canada Ltd. submission in response to the Consultation on the Legislative Review of the Tobacco and Vaping Products Act <https://www.canada.ca/en/health-canada/programs/consultation-legislative-review-tobacco-vaping-products-…

Organization: Health Canada

40 page(s)
October 2024

Req # A-2024-000496

The most current status of the Abbreviated New Drug Submission (ANDS) seeking approval of a generic degarelix acetate product, which was accepted into review by Health Canada in January 2024: Inactive; Process; Process Hold; Withdrawn. If the status…

Organization: Health Canada

1 page(s)
October 2024

Req # A-2024-000497

Provide a screenshot of the status page for the Degarelix Acetate Abbreviated New Drug Submission (ANDS) on the Drug Submission Tracking System (DSTS) interface.

Organization: Health Canada

1 page(s)
October 2024

Req # A-2024-000530

If the Nov 2023 Liraglutide Abbreviated New Drug Submission (ANDS) has received a Notice of Deficiency (NOD); a Notice of Non-Compliance (NON); a NOD-Withdrawal (NOD-W); or a NON-Withdrawal (NON-W), provide the month and year that the notice was…

Organization: Health Canada

7 page(s)
October 2024

Req # A-2024-000532

A screenshot of the status page for the April 2024 Liraglutide Abbreviated New Drug Submission (ANDS) on the Drug Submission Tracking System (DSTS) interface.

Organization: Health Canada

2 page(s)
October 2024

Req # A-2024-000569

The number of requests for exemption under subsection 56(1) of the Controlled Drugs and Substances Act (CDSA) to possess and use psilocybin by province and territory, that were received by the Minister of Health in 2019, 2020, 2021, 2022, 2023, and…

Organization: Health Canada

2 page(s)
October 2024

Req # A-2024-000623

For the time period — October 17, 2018, to December 31, 2023 — the general companion totals to the aggregate data requested under A-2024-000151. If possible, further disaggregate the data disclosed under A-2024-000151 relating to Part 11 according…

Organization: Health Canada

6 page(s)
October 2024

Req # A-2024-000634

Number of psilocybin access requests submitted and granted since January 2022 under the Special Access Program; Number of exemption requests submitted and granted under subsection 56(1) of the Controlled Drugs and Substances Act (between 2020-2022…

Organization: Health Canada

2 page(s)
October 2024

Req # A-2024-000645

With respect to generic drug in Health Canada's list of "Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient mesalazine, the following documents that post-date August 2023: Notice of Deficiency (NOD),…

Organization: Health Canada

0 page(s)
October 2024
Date modified: